# Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals

> **NCT05267483** · — · UNKNOWN · sponsor: **D'Or Institute for Research and Education** · enrollment: 100 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05267483
- **Lead sponsor:** D'Or Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05267483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05267483, "Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05267483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*